NCT04108481 - Immunotherapy With Y90-RadioEmbolization for Metastatic Colorectal Cancer | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 5, 2020

Primary Completion Date

November 17, 2023

Study Completion Date

November 17, 2023

Conditions

Colorectal Cancer MetastaticColon CancerMetastatic Colorectal CancerRectal CancerLiver Metastasis Colon CancerColo-rectal CancerColorectal AdenocarcinomaColorectal NeoplasmsLiver MetastasesColorectal Carcinoma

Interventions

DRUG

Durvalumab

Immunotherapy

RADIATION

Yttrium-90 RadioEmbolization

Microscopic radioactive particles (TheraSphere®) will be used for radioembolization to deliver the Y90 drug to the liver

Trial Locations (1)

52242

University of Iowa Hospitals and Clinics, Iowa City